Hot Features
Premium
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Zeitraum:
Zeichenmodus:
| Volumen | 110.794 |
|
|||||
| News | - | ||||||
| Tageshoch | 8,29 | Niedrig Hoch |
|||||
| Tagestief | 6,90 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Nuvectis Pharma Inc | NVCT | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,94 | 13,91% | 7,70 | 00:48:49 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 6,93 | 6,90 | 8,29 | 8,14 | 6,76 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 1.769 | 110.794 | US$ 7,69 | US$ 851.687 | - | 5,92 - 18,65 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 00:48:39 | formt | 1.000 | US$ 7,70 | USD |
Finanzwerte NVCT
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 143,93M | 17,77M | - | 0 | -22,26M | -1,25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Nuvectis Pharma
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 05.3.2024 | 23:20 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 05.3.2024 | 14:17 | Edgar (US Regulatory) | Form 8-K - Current report |
| 05.1.2024 | 22:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 05.1.2024 | 22:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 08.11.2023 | 14:39 | Edgar (US Regulatory) | Form 8-K - Current report |
| 08.11.2023 | 13:45 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 12.9.2023 | 14:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17.8.2023 | 15:18 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09.8.2023 | 22:51 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 09.8.2023 | 22:29 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09.8.2023 | 22:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 03.7.2023 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Nuvectis Pharma
Keine Diskussionen Gefunden.Neuen Thread Erstellen
NVCT Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 6,52 | 8,29 | 5,92 | 6,31 | 99.684 | 1,18 | 18,10% |
| 1 Monat | 7,82 | 8,29 | 5,92 | 6,66 | 64.853 | -0,12 | -1,53% |
| 3 Monate | 6,99 | 12,10 | 5,92 | 8,50 | 100.574 | 0,71 | 10,16% |
| 6 Monate | 9,12 | 12,10 | 5,92 | 8,34 | 80.723 | -1,42 | -15,57% |
| 1 Jahr | 14,75 | 18,65 | 5,92 | 11,10 | 68.386 | -7,05 | -47,80% |
| 3 Jahre | 3,95 | 20,92 | 3,08 | 8,03 | 208.091 | 3,75 | 94,94% |
| 5 Jahre | 3,95 | 20,92 | 3,08 | 8,03 | 208.091 | 3,75 | 94,94% |
